Facts
as of Nov 17, 2026
Petrovax is a Russian biopharmaceutical company that develops and manufactures immunobiological medicines and vaccines. It runs its own pharmaceutical production with quality assurance, medical affairs including oncology and product management for healthcare professionals. The company is based in Moscow, Russia.
It is hiring: 11 open roles, 11 of them posted in the last 30 days.
- Headquarters
- Moscow, Russia
- Employees
- 51-200estimated range
- Open roles
- 11 in 4 citiesAlion job postings
- Website
- petrovax.ru
As of Nov 17, 2026, Alion lists 11 open roles at Petrovax. Petrovax is headquartered in Moscow, Russia.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Postings are real
Alion truth index: D
40/100
Ghost roles
re-checked against its careers site
80%
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Hiring at full speed: most open roles are fresh.
Field & Service is the largest family, 43 of open roles.
11Posted in 30 days100% of open roles are fresh
36%Remote roles4 of 11
4Hiring offices
Can they hire you from United States?by your location
Closed for your country
None of 4 remote postings in the last year included United States
Russia19On site
Remote, from elsewhere4Rare
No posting offers visa sponsorship. Remote roles: 4.
Time to fillmedian days to close a role
Petrovax24 days
Market, same roles34 days
Alion signals0-100
Demand40
Pay4
Your chance41
How badly they need people, whether they pay, how realistic getting in is.
Open roles over time−100%
Sep 7This week
Open roles a week: 5 then, 0 now
Are the postings real?
D
40 / 100Petrovax scores D on the Alion truth index (A is best, E worst), measured over 5 open roles re-checked against its own hiring board: 80% look like ghost listings, 0% have gone stale and 80% are the same role posted again. Its roles close in a median of 24 days.
Ghost roles80%
Gone stale0%
Reposted80%
Where the openings areshare of open roles · trend
Field & Service43▼
Biotech22▲
Sales9▲
Hardware4▲
Product4▼
Analytics4▲
What postings ask forlanguages named in open roles
Degree asked
Bachelor's Degree 75%Doctoral Degree (PhD) 25%
8 postings state a degree.
Contract type
Full-Time 10
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
Footprint
Hiring in 4 cities in 1 country.
4Cities
1Countries
MoscowBusiest site
Source: office addresses in postings and company registers
Ranked #6 by open roles among its 11 closest peers.
Source: Alion's similar-companies engine (industry segments, technologies, headquarters country, size)
Technologies named in job postings at Petrovax over the last 12 months, by layer, with the share of postings for each.
9Technologies in use
18Postings analysed
76/100Stack modernity
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site
Newsroom
top 2%Web presenceof 133.2M domains by links, Common Crawl
Sep 52026
News · apteka.ru
Купить Форседено 60 мг раствор для подкожного введения 1 мл шприц 1 шт. по цене 7462 руб. в интернет аптеке в Москве, всегда в наличии, инструкция по применению Форседено 60 мг р…
Aug 302026
News · AKM EN
Petrovax Farm
Jun 292026
News · Коммерсантъ
Российская биофармацевтическая компания Петровакс Фарм получила регистрационное удостоверение на свой оригинальный препарат Полиоксидоний в Ботсване, начав таким образом экспанси…
Jun 292026
News · vedomosti
Отечественным производителям покупка готовых решений кажется выгоднее собственных разработок
Jun 222026
News · АПТЕКИУМ
Российские и китайские компании переходят от поставок препаратов к совместной разработке, локализации и выводу инноваций на рынок.
Jun 192026
News · Медпортал
Результаты опубликованы в июне 2026 года в международном журнале Expert Review of Respiratory Medicine
Sources: the outlets named on each headline, each story once